CellCarta Competitors and Similar CompaniesClear all
CellCarta's competitors and similar companies include SOPHiA GENETICS and Illumina.
 CellCarta CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. |  SOPHiA GENETICS SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine. |  Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | |
Founding Date | Founding Date 2001 | Founding Date 2011 | Founding Date 1998 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Antwerpen, BE HQ Berchem, BE Naperville, US | Locations Rolle, CH HQ Bidart, FR Boston, US | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more |
Employees | Employees 4 | Employees 423 | Employees 8,6004% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 236.4 m | Valuation ($) 23.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $77.3m (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $19.9m (FY, 2025) | Cost of goods $1.5b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $57.4m (FY, 2025) | Gross profit $2.9b (FY, 2025) |
Net income | Net income N/A | Net income ($79m) (FY, 2025) | Net income $850m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 245.8m | Total funding raised $ 28m |
For sources of this data, please see the company profile
View Company Profiles
SOPHiA GENETICS
HQ
Rolle, CH
Employees
423
SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.
View companyIllumina
HQ
San Diego, US
Employees
8,600↓ 4% decrease
Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company